Feb 09, 2021 8:30am EST ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations
Feb 01, 2021 8:30am EST ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
Jan 29, 2021 8:30am EST ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
Jan 11, 2021 8:30am EST ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
Jan 05, 2021 12:10pm EST ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
Dec 08, 2020 4:15pm EST ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
Nov 16, 2020 8:30am EST ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020